Biologia reprodutiva de Heros efasciatus Heckel, 1840 (Pisces, Cichlidae) na Reserva de Desenvolvimento Sustentável Amanã-AM, visando seu manejo sustentável

Com o principal objetivo de fornecer ferramentas para auxiliar na implementação do manejo sustentável de peixes ornamentais na Reserva de Desenvolvimento Sustentável Amanã, Amazonas, foi realizado o estudo da biologia reprodutiva de Heros efasciatus Heckel, 1840, um ciclídeo com potencial ornamental e com poucos trabalhos sobre a sua biologia e ecologia, apesar de já ser comercializado em algumas regiões amazônicas. Coletas bimestrais foram realizadas de fevereiro de 2006 a janeiro de 2007 em dez igarapés contribuintes do Lago Amanã e Urini, sendo utilizados três aparelhos de pesca (rede de arrasto, rapiché e armadilha tipo matapi) e ainda galhadas artificiais nas amostragens realizadas próximas aos lagos. Foram capturados 140 exemplares de H. efasciatus, sendo 50 fêmeas, 42 machos, e 46 indivíduos cujo sexo não foi identificado devido ao pequeno tamanho. O tipo de crescimento encontrado foi isométrico, sendo que o maior indivíduo observado apresentava 174 mm e o menor 14 mm. Os resultados encontrados auxiliarão na adoção de medidas de manejo, como a determinação de tamanhos mínimos de captura, superiores aos tamanhos médios de maturação (97 mm para as fêmeas) e o estabelecimento de períodos de defeso durante a época de sua reprodução (outubro a janeiro). A pequena abundância de indivíduos da espécie, quando comparada com o total de exemplares capturados (apenas 0,07%) e a baixa fecundidade média, de 2502 ovócitos, indica que se deve trabalhar anualmente apenas com um pequeno número de indivíduos, a fim de garantir a continuidade do estoque.

From ""Geography of Accumulation"" to ""Geography of Reproduction"": a dialogue with Harvey

This article aims to discuss the space, revealing its powerful in the comprehension of modem world, from the thesis which the geographic space consists itself as condition, medium and product of society reproduction in its totality, evolving several temporal-spatial scales and several levels of reality, that should prolong Marx's work, having in view the construction of a ""social theory of space"" in the sense of a radical critical geography. This argumentation allows to understand, in the limits of geography, the passage of the notion ""production of space"" as condition of the accumulation of capital to the notion ""production of space"" as condition of present reproduction in front of the accumulation crisis. As a starting point, a discussion about some David Harvey's works, who supports the thesis that accumulation crisis of capital would be solved, in the modem world, through the spatial fix.

Shallow-water species of Beania Johnston, 1840 (Bryozoa, Cheilostomata) from the tropical and subtropical Western Atlantic

This paper describes four new species of the bryozoan genus Beania from the Brazilian coast. Two of them have been previously recorded in the western Atlantic as Beania hirtissima (Heller, 1867) and Beania mirabilis Johnston, 1840, respectively; they are redescribed here as Beania americana n. sp. and Beania mirabilissima n. sp. Two reticulate species, Beania correiae n. sp. and Beania metrii n. sp., are newly described. Descriptions of four other species of Beania from the region are also included: Beania australis Busk, 1852, Beania cupulariensis Osburn, 1914, Beania klugei Cook, 1968 and Beania maxilladentata Ramalho, Muricy & Taylor, 2010.

Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, Sao Paulo, Brazil

To discuss and share knowledge around advances in the care of patients with thrombotic disorders, the Third International Symposium of Thrombosis and Anticoagulation was held in So Paulo, Brazil, from October 14-16, 2010. This scientific program was developed by clinicians for clinicians, and was promoted by four major clinical research institutes: the Brazilian Clinical Research Institute, the Duke Clinical Research Institute of the Duke University School of Medicine, the Canadian VIGOUR Centre, and the Uppsala Clinical Research Center. Comprising 3 days of academic presentations and open discussion, the symposium had as its primary goal to educate, motivate, and inspire internists, cardiologists, hematologists, and other physicians by convening national and international visionaries, thought-leaders, and dedicated clinician-scientists. This paper summarizes the symposium proceedings.

The Alzheimer`s Association external quality control program for cerebrospinal fluid biomarkers

Background: The cerebrospinal fluid (CSF) biomarkers amyloid beta (A beta)-42, total-tau (T-tau), and phosphorylated-tau (P-tau) demonstrate good diagnostic accuracy for Alzheimer`s disease (AD). However, there are large variations in biomarker measurements between studies, and between and within laboratories. The Alzheimer`s Association has initiated a global quality control program to estimate and monitor variability of measurements, quantify batch-to-batch assay variations, and identify sources of variability. In this article, we present the results from the first two rounds of the program. Methods: The program is open for laboratories using commercially available kits for A beta, T-tau, or P-tau. CSF samples (aliquots of pooled CSF) are sent for analysis several times a year from the Clinical Neurochemistry Laboratory at the Molndal campus of the University of Gothenburg, Sweden. Each round consists of three quality control samples. Results: Forty laboratories participated. Twenty-six used INNOTEST enzyme-linked immunosorbent assay kits, 14 used Luminex xMAP with the INNO-BIA AlzBio3 kit (both measure A beta-(1-42), P-tau(181P), and T-tau), and 5 used Mesa Scale Discovery with the A beta triplex (A beta N-42, A beta N-40, and A beta N-38) or T-tau kits. The total coefficients of variation between the laboratories were 13% to 36%. Five laboratories analyzed the samples six times on different occasions. Within-laboratory precisions differed considerably between biomarkers within individual laboratories. Conclusions: Measurements of CSF AD biomarkers show large between-laboratory variability, likely caused by factors related to analytical procedures and the analytical kits. Standardization of laboratory procedures and efforts by kit vendors to increase kit performance might lower variability, and will likely increase the usefulness of CSF AD biomarkers. (C) 2011 The Alzheimer`s Association. All rights reserved.